Macclesfield, United Kingdom

Francis Thomas Boyle

USPTO Granted Patents = 33 

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 219(Granted Patents)


Location History:

  • Cangleton, GB (1998)
  • Ends Congleton, GB (2001)
  • Congleton, GB (1981 - 2004)
  • Macclesfield Cheshire, GB (2004 - 2006)
  • Cheshire, GB (1991 - 2009)
  • Macclesfield, GB (1980 - 2010)

Company Filing History:


Years Active: 1980-2010

Loading Chart...
33 patents (USPTO):Explore Patents

Title: The Legacy of Innovator Francis Thomas Boyle

Introduction: Francis Thomas Boyle, a visionary inventor hailing from Macclesfield, GB, stands as a testament to the power of innovation and individual impact on shaping the future. With 33 patents to his name, Boyle's relentless pursuit of excellence continues to inspire generations of inventors worldwide.

Latest Patents: Among Boyle's latest patents is the groundbreaking invention of N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agent. Additionally, his work on 4-substituted quinolines as antitumor agents showcases his dedication to advancing the field of medicine.

Career Highlights: Boyle has made significant contributions during his tenure at renowned companies such as Imperial Chemical Industries Limited and AstraZeneca AB. His innovative spirit and commitment to groundbreaking research have left an indelible mark on the industry.

Collaborations: Throughout his career, Boyle has collaborated with esteemed colleagues such as James Michael Wardleworth and Zbigniew S. Matusiak. These collaborations have led to innovative breakthroughs and advancements in the field of pharmacology.

Conclusion: Francis Thomas Boyle's remarkable journey as an inventor underscores the transformative power of innovation and the lasting impact of one individual's dedication to pushing the boundaries of what is possible. His legacy serves as a beacon of inspiration for aspiring inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…